Position in NGNE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
11 quarters on record
Common Shares in NGNE Over Time
Shares Held
Position Value (USD)
Derivatives in NGNE
reported options exposure · as of Jun 30, 2026CallValue
$2,905,980
CallShares
92,400
PutValue
$462,315
PutShares
14,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,649,997,309 across 349 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
1,053,896 | $140,442,180 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,549,458 | $131,998,327 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
180,219 | $112,373,755 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
294,460 | $88,641,293 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
148,610 | $79,796,139 | |
| 6 | INSM |
INSMED Inc
|
729,354 | $77,763,723 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
144,174 | $71,615,550 | |
| 8 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,375,558 | $51,046,957 |
All Filings in NGNE
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,905,980 | 92,400 | Call | Other | 2026-08-14 | |
| 2026-06-30 | $462,315 | 14,700 | Put | Other | 2026-08-14 | |
| 2026-03-31 | $2,538,144 | 125,900 | Call | Other | 2026-05-15 | |
| 2026-03-31 | $550,368 | 27,300 | Put | Other | 2026-05-15 | |
| 2025-12-31 | $206,000 | 10,000 | Call | Other | 2026-02-17 | |
| 2025-09-30 | $207,960 | 12,000 | Put | Other | 2025-11-14 | |
| 2025-09-30 | $403,789 | 23,300 | Call | Other | 2025-11-14 | |
| 2025-06-30 | $1,408,290 | 94,200 | Call | Other | 2025-08-14 | |
| 2025-06-30 | $388,789 | 26,006 | Shares | Other | 2025-08-14 | |
| 2025-06-30 | $447,005 | 29,900 | Put | Other | 2025-08-14 | |
| 2025-03-31 | $168,682 | 14,405 | Shares | Other | 2025-05-14 | |
| 2025-03-31 | $386,430 | 33,000 | Put | Other | 2025-05-14 | |
| 2025-03-31 | $511,727 | 43,700 | Call | Other | 2025-05-14 | |
| 2024-12-31 | $434,340 | 19,000 | Call | Other | 2025-02-14 | |
| 2024-12-31 | $4,402,836 | 192,600 | Put | Other | 2025-02-14 | |
| 2024-12-31 | $1,709,425 | 74,778 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $1,688,470 | 40,240 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,483,438 | 40,765 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $6,681,032 | 131,258 | Shares | Defined | 2024-05-07 | |
| 2023-09-30 NLTX | — | 13,154 | Shares | Defined | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||